BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT06425302 updates: 1. primary completion date: 2026-11-23 → 2026-06-19 2. enrollment: 90 → 95 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06425302 updates: 1. primary completion date: 2026-11-23 → 2026-06-19 2. enrollment: 90 → 95 participants 3. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical